2018
DOI: 10.1016/j.biochi.2018.07.027
|View full text |Cite
|
Sign up to set email alerts
|

The effect of electronic-cigarettes aerosol on rat brain lipid profile

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
8
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
10

Relationship

1
9

Authors

Journals

citations
Cited by 18 publications
(9 citation statements)
references
References 43 publications
1
8
0
Order By: Relevance
“…Gene enrichment analyses revealed a significant change (p = 0.049) in the expression of lncRNAs involved in steroid binding in the plasma-derived exosomes from E-cig users as compared to their nonsmoking controls. This supports the findings from previous studies that show disruption in lipid metabolism on E-cig use [59][60][61].…”
Section: Plos Onesupporting
confidence: 91%
“…Gene enrichment analyses revealed a significant change (p = 0.049) in the expression of lncRNAs involved in steroid binding in the plasma-derived exosomes from E-cig users as compared to their nonsmoking controls. This supports the findings from previous studies that show disruption in lipid metabolism on E-cig use [59][60][61].…”
Section: Plos Onesupporting
confidence: 91%
“…On the contrary, effects on PUFAs in EC-users were consistent with a previous study reporting lower concentration of AA in the brains of rats exposed to EC for 8 weeks. 62 In addition, the study of Canistro et al 63 showed that rats exposed to EC for 4 consecutive weeks exhibited significant reduction in the plasma concentrations of a sum measure of various omega-6 PUFAs that included both AA and LA as compared with the nonexposed control group. Importantly, we found that EC-users who had never smoked TCs also exhibited lower LA and AA concentrations in comparison to those who were former TC-smokers, indicating that these effects in chronic EC uses were not due to carryover effect due to TC smoking in the previous years (Figure VIII in the Data Supplement).…”
Section: Discussionmentioning
confidence: 99%
“…The exposure apparatus was comparable to those described in previous studies. [11][12][13] The treated group was exposed using a whole-body mode. The inhalation chamber consisted of a propylene chamber (38 × 26.5 × 19 cm) with a capacity of 19 L. The pump (0.18 kW; 1.4/1.6 A; 230 V; 50/60 Hz) was installed on one side of the box, while the IQOS aerosol was puffed on the other, generating the airflow into the chamber.…”
Section: Animal Exposurementioning
confidence: 99%